Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Lisata Therapeutics Inc (LSTA)

Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lisata Therapeutics Inc 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 USA

www.lisata.com Employees: 25 P: 908-842-0100

Description:

Lisata Therapeutics Inc. is a clinical-stage biopharmaceutical company. It involved in discovery, development and commercialization of therapies for the treatment of advanced solid tumors and other major diseases. The company's principal product candidate includes LSTA1. Lisata Therapeutics Inc., formerly known as Caladrius Biosciences Inc., is based in BASKING RIDGE, N.J.

Key Statistics

Overview:

Market Capitalization, $K 26,276
Enterprise Value, $K 3,686
Shares Outstanding, K 8,395
Annual Sales, $ 0 K
Annual Net Income, $ -20,840 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,930 K
EBIT, $ -23,490 K
EBITDA, $ -24,260 K
60-Month Beta 1.16
% of Insider Shareholders 9.10%
% of Institutional Shareholders 8.94%
Float, K 7,631
% Float 90.90%
Short Volume Ratio 0.42

Growth:

1-Year Return 6.47%
3-Year Return -75.21%
5-Year Return -92.55%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 89.70%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.59 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -2.51
EPS Growth vs. Prev Qtr 3.28%
EPS Growth vs. Prev Year 9.23%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 09/15/22

LSTA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -51.19%
Return-on-Assets % -45.16%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.77
Book Value/Share 4.02
Interest Coverage -0.79
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar